Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Cancer is a leading global cause of death, often diagnosed late, with high relapse rates after conventional treatments like chemotherapy.
• Chemotherapy lacks specificity, affecting normal cells alongside cancerous ones, necessitating safer, more effective therapeutic strategies.
• Gene therapy aims to introduce therapeutic genes into host cells for a beneficial biological effect, but clinical efficacy remains limited.

Purpose of the Study:

• To review advancements in targeting gene therapy using cancer- and tumor-specific promoters.
• To explore various gene therapy strategies, including gene editing and silencing.
• To discuss the role of different delivery vehicles in enhancing gene therapy efficacy.

Main Methods:

• Review of scientific literature on gene therapy for cancer.
• Analysis of tumor-specific promoter systems for targeted gene delivery.
• Examination of different gene therapy approaches (suppressor genes, suicide genes, anti-angiogenesis, silencing, editing).
• Evaluation of viral and non-viral delivery vehicles for specificity and efficacy.

Main Results:

• Tumor-specific promoters enable targeted expression of therapeutic genes, increasing localized activity and reducing systemic toxicity.
• Development of various promoter systems and delivery vehicles aims to improve gene therapy specificity and effectiveness.
• Gene therapy strategies encompass diverse approaches like gene silencing and editing for cancer treatment.

Conclusions:

• Targeting gene therapy with cancer- and tumor-specific promoters is crucial for improving treatment efficacy and patient survival.
• Gene therapy holds potential as a complementary approach to traditional cancer treatments.
• Further research into optimized delivery vehicles and promoter systems is essential for realizing the full clinical potential of gene therapy.